192P Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis

Publication/Presentation Date

4-2022

Volume

33

Issue

2

First Page

118

Last Page

118

Disciplines

Medicine and Health Sciences | Oncology

Department(s)

Department of Radiation Oncology

Document Type

Article

Share

COinS